Robert R. Lavieri
Vanderbilt University(US)Vanderbilt University Medical Center(US)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Computational Drug Discovery Methods, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Pregnancy and Medication Impact
Most-Cited Works
- → Phospholipase D: Enzymology, Functionality, and Chemical Modulation(2011)377 cited
- → Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity(2009)98 cited
- → Design, Synthesis, and Biological Evaluation of Halogenated N-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: Discovery of an Isoform-Selective Small Molecule Phospholipase D2 Inhibitor(2010)90 cited
- → Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity(2009)66 cited
- → Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data(2019)59 cited
- → Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19(2023)49 cited
- → Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics(2017)47 cited
- → Discovery of Desketoraloxifene Analogues as Inhibitors of Mammalian, Pseudomonas aeruginosa, and NAPE Phospholipase D Enzymes(2014)47 cited
- → Machine learning on drug-specific data to predict small molecule teratogenicity(2020)27 cited
- → Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study(2020)21 cited